Pregnancy and infant outcomes by trimester of SARS-CoV-2 infection in pregnancy-SET-NET, 22 jurisdictions, January 25, 2020-December 31, 2020.
Varsha NeelamEmily L ReevesKate E RussellEmily O'Malley OlsenMegan R ReynoldsJoy RendeHeather WingateSusan E ManningPaul A RomittiKristen D OjoKristin SilcoxJerusha BartonEvan MobleyNicole D LongcoreAyomide SokaleMamie LushCamille Delgado-LopezAbdoulaye DiedhiouDeborah MbothaWanda SimonBethany ReynoldsTahani S HamdanSuzann BeauregardEsther M EllisJennifer Y SeoAmanda BennettSascha R EllingtonAron J HallEduardo Azziz-BaumgartnerVan T TongSuzanne M GilboaPublished in: Birth defects research (2022)
There were no signals for increased birth defects among infants in this population relative to national baseline estimates, regardless of timing of infection. However, the prevalence of preterm birth in people with SARS-CoV-2 infection in pregnancy in our analysis was higher relative to national baseline data (10.0-10.2%), particularly among people with third trimester infection. Consequences of COVID-19 during pregnancy support recommended COVID-19 prevention strategies, including vaccination.